Liquidia
Manufacturing · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
419 Davis Dr Ste 100, Morrisville, North...Phone Number
(919) 328-4400Website
www.liquidia.comRevenue
$450.9 MillionStock Symbol
LQDAIndustry
About Liquidia
Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation, is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. Liquidia is headquartered in Research Triangle Park, NC.Explore more
Liquidia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Liquidia
Compare insights from companies similar to Liquidia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$12.2M
11-50
Private
<$5M
1981
JS
Jonathan Schwartz(Performing At Director, Operations & Vice President, Level)
Liquidia Tech Stack
A closer look at the technologies used by Liquidia
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Liquidia
Sign Up For FreeTo access detailed company insights
Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation, is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of... Read More
